Connective tissue dysplasia in females with primary knee and hip osteoarthritis

Abstract

Aim. Assessment of the prevalence of connective tissue dysplasia markers in women with primary knee and hip osteoarthritis.

Methods. 203 females were examined in a cross-sectional study, with median age 58 years (55-62 years) and duration of post-menopause for 8 years (5.0-12.0 years). Severity of postmenopausal syndrome was defined by modified menopause index scores with the assessment of neurovegetative, metabolic and endocrine and psychoemotional symptoms. Backache and joint pain were assessed by visual analogue scale. Osteoarthritis was diagnosed according to clinical and radiologic criteria.

Results. In 153 patients primary osteoarthritis stage 2-3 was diagnosed (group 1), group 2 included 50 patients without osteoarthritis. Screening for connective tissue dysplasia was performed by steps. At first, L.V. Solovyova’s phenotypic screening scale modified by T.F. Peretolchina was used, and cut-off score of 1.92 points was found in 6 (12%) patients without osteoarthritis and 44 (28.8%) in osteoarthritis group, that allowed suggesting connective tissue dysplasia. Then international M.J. Glesby phenotypic scale was used: 53 (34.6%) patients with osteoarthritis and only 1 (2%) subject without osteoarthritis had three and more phenotypic traits (χ2=18.925, р <0.001), that confirms connective tissue dysplasia. On step three, according to Russian guidelines on «Inherited disorders of connective tissue» (Russian scientific society of cardiology, 2012), among examined patients three phenotypes of connective tissue dysplasia were determined: (1) joint hypermobility syndrome; (2) increased dysplastic stigmatization and (3) increased, mostly visceral dysplastic stigmatization. The latter was more prevalent in females with osteoarthritis.

Conclusion. High prevalence of connective tissue dysplasia criteria in primary osteoarthritis patients confirms the presence of dysplastic osteoarthritis phenotype and necessity of personalized attitude to patient management.

Keywords

knee and hip osteoarthritis / connective tissue dysplasia / hypermobility syndrome / females / post-menopause

References

[1] Alekseeva L.I. New approaches to treatment of patients with osteoarthrosis in actual clinical practice. Practicheskaya meditsina. 2015; 3-2 (88): 77–83. (In Russ.)

[2] Алексеева Л.И. Новые подходы к ведению больных остеоартрозом в реальной клинической практике. Практич. мед. 2015; (3-2): 77-83.

[3] Brandt K.D., Radin E.L., Dieppe P.A., van de Putte L. Yet more evidence that osteoarthritis is not a cartilage disease. Ann. Rheum. Dis. 2006; 65 (10): 1261–1264. DOI: 10.1136/ard.2006.058347.

[4] Brandt K.D., Radin E.L., Dieppe P.A., van de Putte L. Yet more evidence that osteoarthritis is not a cartilage disease. Ann. Rheum. Dis. 2006; 65 (10): 1261-1264. DOI: 10.1136/ard.2006.058347.

[5] Loughlin J., Irven K., Athanasou N. et al. Differential Allelic Expression of the Type II Collagen Gene (COL2AI) in Osteoarthritic Cartilage. American Society of Human Genetics. 1995; 56: 1186–1193. PMID: 7726176.

[6] Loughlin J., Irven K., Athanasou N. et al. Differential Allelic Expression of the Type II Collagen Gene (COL2AI) in Osteoarthritic Cartilage. American Society of Human Genetics. 1995; 56: 1186-1193. PMID: 7726176.

[7] Jimenez S.A., Dharmavaram R.M. Genetic aspects of familial osteoarthritis. Ann. Rheum. Dis. 1994; 53: 789–797. DOI: 10.1136/ard.53.12.789.

[8] Jimenez S.A., Dharmavaram R.M. Genetic aspects of familial osteoarthritis. Ann. Rheum. Dis. 1994; 53: 789-797. DOI: 10.1136/ard.53.12.789.

[9] Committee of experts of the Russian society of cardiology. Hereditary disorders of connective tissue. Russian guidelines. Moscow. 2012; 76 р. (In Russ.)

[10] Комитет экспертов Всероссийского общества кардиологов. Наследственные нарушения соединительной ткани. Российские рекомендации. М. 2012; 76 с.

[11] Altman R., Asch E., Bloch D. et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum. 1986; 29: 1039–1049. DOI: 10.1002/art.1780290816.

[12] Altman R., Asch E., Bloch D. et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum. 1986; 29: 1039-1049. DOI: 10.1002/art.1780290816.

[13] Kokotova E.P., Peretolchina T.F. Analysis of detection of clinical phenotypic manifestations of undifferentiated connective tissue dysplasia syndrome in the digestive system. Vestnik of Ural state medical academy. 2013; 26: 30–36. (In Russ.)

[14] Кокотова Е.П., Перетолчина Т.Ф. Анализ выявляемости клинико-фенотипических проявлений синдрома недифференцированной дисплазии соединительной ткани со стороны органов пищеварения. Вестн. Уральской гос. мед. академии. 2013; 26: 30-36.

[15] Glesby M.J., Pyeritz R.E. Association of mitral valve prolapse and systemic abnormalities of connective tissue. A phenotypic continuum. JAMA. 1989; 262: 523–528. DOI: 10.1001/jama.1989.03430040095032.

[16] Glesby M.J., Pyeritz R.E. Association of mitral valve prolapse and systemic abnormalities of connective tissue. A phenotypic continuum. JAMA. 1989; 262: 523-528. DOI: 10.1001/jama.1989.03430040095032.

[17] Kadurina T.I., Gorbunova V.N. Displaziya soedinitel’noy tkani. (Connective tissue dysplasia.) Saint Petersburg: ELBI-SPb. 2009; 295–299. (In Russ.)

[18] Кадурина Т.И., Горбунова В.Н. Дисплазия соединительной ткани. СПб.: ЭЛБИ-СПб. 2009; 295-299.

[19] Sokolov V.A. The structural peculiarities of connective tissue dysplasias in case of chronic somatic diseases and joint diseases of adults. Meditsinskiy Al'manakh. 2013; (6): 202–204. (In Russ.)

[20] Соколов В.А. Структурные особенности соединительнотканных дисплазий при хронических соматических заболеваниях и заболеваниях суставов у взрослых. Мед. альманах. 2013; (6): 202-204.

[21] Bochkova D.N., Ternova T.I., Kostikov M.V., Fyodorov A.M. Ehlers–Danlos syndrome. Therapevticheskiy arkhiv. 1985; (4): 140–143. (In Russ.)

[22] Бочкова Д.Н., Тернова Т.И., Костиков М.В., Фёдоров A.M. Синдром Элерса-Данлоса. Терап. архив. 1985; (4): 140-143.

[23] Belenkiy A.G. Phenotypic signs in joint hypermobility in adults. Nauchno-prakticheskaya revmatologiya. 2002; (4): 18–21. (In Russ.)

[24] Беленький А.Г. Фенотипические признаки при гипермобильности суставов у взрослых лиц. Науч.-практич. ревматол. 2002; (4): 18-21.

[25] Ritvaniemi P., Körkkö J., Bonaventure J. et al. Identification of COL2A1 gene mutations in patients with chondrodysplasias and familial osteoarthritis. Arthritis and rheumatism. 1995; 38 (7): 999–1004. DOI: 10.1002/art.1780380717.

[26] Ritvaniemi P., Körkkö J., Bonaventure J. et al. Identification of COL2A1 gene mutations in patients with chondrodysplasias and familial osteoarthritis. Arthritis and rheumatism. 1995; 38 (7): 999-1004. DOI: 10.1002/art.1780380717.

[27] Scheper M.C., Vries J.E., Verbunt J. et al. Chronic pain in hypermobility syndrome and Ehlers–Danlos syndrome (hypermobility type): it is a challenge? J. Pain Res. 2015; 8: 591–601. DOI: 10.2147/JPR.S64251.

[28] Scheper M.C., Vries J.E., Verbunt J. et al. Chronic pain in hypermobility syndrome and Ehlers-Danlos syndrome (hypermobility type): it is a challenge? J. Pain Res. 2015; 8: 591-601. DOI: 10.2147/JPR.S64251.

[29] Hakim A.J., Grahame R. A simple questionnaire to detect hypermobility: an adjunct to the assessment of patients with diffuse musculoskeletal pain. Intern. J. Clin. Pract. 2003; 57: 163–166. PMID: 12723715.

[30] Hakim A.J., Grahame R. A simple questionnaire to detect hypermobility: an adjunct to the assessment of patients with diffuse musculoskeletal pain. Intern. J. Clin. Pract. 2003; 57: 163-166. PMID: 12723715.

[31] Alakokko L., Baldwin C.T., Moskowittz R.W. et al. Single base mutation in the type II procollagen gene (COL2AI) as a cause of primary osteoarthritis associated with a mild chondrodysplasia. Proceedings of the National Academy of Science USA, Genetics. 1990; 87: 6565–6568. DOI: 10.1073/pnas.87.17.6565.

[32] Alakokko L., Baldwin C.T., Moskowittz R.W. et al. Single base mutation in the type II procollagen gene (COL2AI) as a cause of primary osteoarthritis associated with a mild chondrodysplasia. Proceedings of the National Academy of Science USA, Genetics. 1990; 87: 6565-6568. DOI: 10.1073/pnas.87.17.6565.

[33] Reinstein E.E., Pariani M.M., Lachman R.S. et al. Early-onset osteoarthritis in Ehlers–Danlos syndrome type VIII. Am. J. Med. Genet. Part A. 2012; 158A (4): 938–941. DOI: 10.1002/ajmg.a.35261.

[34] Reinstein E.E., Pariani M.M., Lachman R.S. et al. Early-onset osteoarthritis in Ehlers-Danlos syndrome type VIII. Am. J. Med. Genet. Part A. 2012; 158A (4): 938-941. DOI: 10.1002/ajmg.a.35261.

[35] Tyurin V.A., Davletshin R.A. To the questions of osteoarthritis pathogenesis and connective tissue dysplasia. Meditsinskiy vestnik Bashkortostana. 2013; 8 (4): 80–83. (In Russ.)

[36] Тюрин А.В., Давлетшин Р.А. К вопросам патогенеза остеоартрита и дисплазии соединительной ткани. Мед. вестн. Башкортостана. 2013; 8 (4): 80-83.

[37] Golightly Y.M. General joint hypermobility and hip osteoarthritis: the Johnston county osteoarthritis project. Osteoarthritis and Cartilage. 2012; 20: 182. DOI: 10.1016/j.joca.2012.02.280.

RIGHTS & PERMISSIONS

Izmozherova N.V., Getmanova N.A., Popov A.A., Peretolchina T.F.